<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">ojrdrt</journal-id><journal-title-group><journal-title xml:lang="ru">Онкологический журнал: лучевая диагностика, лучевая терапия</journal-title><trans-title-group xml:lang="en"><trans-title>Journal of oncology: diagnostic radiology and radiotherapy</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2587-7593</issn><issn pub-type="epub">2713-167X</issn><publisher><publisher-name>НЕКОММЕРЧЕСКОЕ ПАРТНЕРСТВО «ОБЩЕСТВО ИНТЕРВЕНЦИОННЫХ ОНКОРАДИОЛОГОВ»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.37174/2587-7593-2020-3-4-18-25</article-id><article-id custom-type="elpub" pub-id-type="custom">ojrdrt-141</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ЛУЧЕВАЯ ТЕРАПИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>RADIOTHERAPY</subject></subj-group></article-categories><title-group><article-title>Определение объемов облучения при дистанционной лучевой терапии глиом высокой степени злокачественности</article-title><trans-title-group xml:lang="en"><trans-title>Target Volume Delineation for Radiation Therapy of High-Grade Gliomas</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9914-8990</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шейко</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Sheiko</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Шейко Андрей Владимирович — заведующий радио терапевтическим отделением № 2 ГБУЗ ВО «Област ной клинический онкологический диспансер»</p><p>600020, Владимир, ул. Каманина, 21</p><p>SPIN-код: 4314-4884</p></bio><bio xml:lang="en"><p>21 Kamanina str., Vladimir, 600020</p></bio><email xlink:type="simple">andreysheyko87@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ГБУЗ ВО «Областной клинический онкологический диспансер»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Vladimir Regional Clinical Oncology Center</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>31</day><month>12</month><year>2020</year></pub-date><volume>3</volume><issue>4</issue><fpage>18</fpage><lpage>25</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Шейко А.В., 2020</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="ru">Шейко А.В.</copyright-holder><copyright-holder xml:lang="en">Sheiko A.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.oncoradjournal.ru/jour/article/view/141">https://www.oncoradjournal.ru/jour/article/view/141</self-uri><abstract><p>Глиомы высокой степени злокачественности характеризуются быстрым ростом, неблагоприятным прогнозом и частыми неудовлетворительными результатами лечения. Лучевая терапия остается одним из основных методов лечения данного заболевания. Однако до сих пор вопрос выбора оптимального макроскопического (Gross Tumor Volume — GTV) и клинического (Clinical Target Volume — CTV) объемов при планировании лучевого лечения остается спорным. Существует несколько подходов к определению радиотерапевтических объемов при лучевом лечении глиом высокой степени злокачественности в зависимости от отношения к перитуморальному отеку. Корреляции между частотой центральных рецидивов и методиками оконтуривания глиом высокой степени злокачественности обнаружено не было. GTV должен определяться как зона повышенного сигнала на постконтрастном взвешенном по Т1 МРТ-изображении, т.е. GTV должен включать послеоперационную полость и остаточную опухоль. Перитуморальный отек — ненадежный ориентир при оконтуривании целевых объемов.</p></abstract><trans-abstract xml:lang="en"><p>High-grade gliomas are characterized by rapid growth, poor prognosis and frequent unsatisfactory treatment results. Radiation therapy remains one of the main methods of treatment of this disease. However, the question of choosing the optimal macroscopic (Gross Tumor Volume — GTV) and clinical (Clinical Target Volume — CTV) volumes in the planning of radiation treatment remains controversial. There are several approaches to the target volume delineation for radiotherapy of high-grade gliomas, depending on the peritumoral edema. There is no correlation between the frequency of recurrences and methods of delineation of gliomas. GTV should be defined as the area of enhancement on the post-contrast T1-weighted MRI, i.e. postoperative cavity and residual tumor. Peritumoral edema is an unreliable orienting point when contouring target volumes.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>глиома высокой степени злокачественности</kwd><kwd>глиобластома</kwd><kwd>отек</kwd><kwd>лучевая терапия</kwd><kwd>объемы облучения</kwd><kwd>CTV</kwd><kwd>GTV</kwd></kwd-group><kwd-group xml:lang="en"><kwd>high-grade glioma</kwd><kwd>glioblastoma</kwd><kwd>edema</kwd><kwd>radiоtherapy</kwd><kwd>target volume</kwd><kwd>CTV</kwd><kwd>GTV</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Каприн АД, Старинский ВВ, Петрова ГВ. Злокачественные новообразования в России в 2018 году (заболеваемость и смертность). М. 2019; 14 с.</mixed-citation><mixed-citation xml:lang="en">Kaprin AD, Starinskii VV, Petrova GV. Malignant neoplasms in Russia in 2018 (prevalence of disease and mortality). Moscow. 2019. 14. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Каприн АД, Старинский ВВ, Шахзадова АО. Состояние онкологической помощи населению России в 2019 году. М. 2020; 231 с.</mixed-citation><mixed-citation xml:lang="en">Kaprin AD, Starinskii VV, Shakhzadova AO. Condition of the oncology aid to the population of Russia in 2019. Moscow. 2020. 231. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Давыдов МИ, Петровский АВ. Онкология. Клинические рекомендации — 2-е изд., испр. и доп. М. 2018; 938 с.</mixed-citation><mixed-citation xml:lang="en">Davydov MI, Petrovsky AV. Oncology. Clinical recommendations. 2nd ed. Moscow. 2018. 938 p. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Hayat MA. Tumors of the Central Nervous System. Volume 1. Gliomas: Glioblastoma (Part 1). Springer, 2011.</mixed-citation><mixed-citation xml:lang="en">Hayat MA. Tumors of the Central Nervous System. Volume 1. Gliomas: Glioblastoma (Part 1). Springer, 2011.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Кобяков ГЛ, Бекяшев АХ, Голанов АВ, Коновалов АН, Насхлеташвили ДР, Потапов АА и др. Практические рекомендации по лекарственному лечению первичных опухолей центральной нервной системы. Злокачественные опухоли: Практические рекомендации RUSSCO #3s2. 2018 (том 8). 83-99 с.</mixed-citation><mixed-citation xml:lang="en">Kobyakov GL, Bekyashev AH, Golanov AV, Konovalov AN, Naskhletashvili DR, Potapov AA, et al. Practical recommendations for drug treatment of primary tumors of the сentral nervous system. Malignant tumors: Practical recommendations RUSSCO #3s2. 2018 (vol. 8). P: 83-99 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Chang EL, Brown P, Lo SS, et al. Adult CNS Radiation Oncology. Principles and Practice. Springer, 2018:85-7.</mixed-citation><mixed-citation xml:lang="en">Chang EL, Brown P, Lo SS, et al. Adult CNS Radiation Oncology. Principles and Practice. Springer, 2018:85-7.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Nayak L, Reardon DA. High-grade Gliomas. CONTINUUM: Lifelong Learning in Neurology. 2017;23(6):1548-63. DOI: 10.1212/con.0000000000000554.</mixed-citation><mixed-citation xml:lang="en">Nayak L, Reardon DA. High-grade Gliomas. CONTINUUM: Lifelong Learning in Neurology. 2017;23(6):1548-63. DOI: 10.1212/con.0000000000000554.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Beyzadeoglu M, Ozyigit G, Ebruli C. Basic Radiation Oncology. Springer, 2010. Р. 189-91.</mixed-citation><mixed-citation xml:lang="en">Beyzadeoglu M, Ozyigit G, Ebruli C. Basic Radiation Oncology. Springer, 2010. Р. 189-91.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Barrett A, Dobbs J, Morris S, Roques T. Practical Radiotherapy Planning, 4th ed. Hodder Arnold, an imprint of Hodder Education, an Hachette UK Company, 2009. 207 p.</mixed-citation><mixed-citation xml:lang="en">Barrett A, Dobbs J, Morris S, Roques T. Practical Radiotherapy Planning, 4th ed. Hodder Arnold, an imprint of Hodder Education, an Hachette UK Company, 2009. 207 p.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Mann J, Ramakrishna R, Magge R, et al. Advances in Radiotherapy for Glioblastoma. Front. Neurol. 2018;8:748. DOI: 10.3389/fneur.2017.00748.</mixed-citation><mixed-citation xml:lang="en">Mann J, Ramakrishna R, Magge R, et al. Advances in Radiotherapy for Glioblastoma. Front. Neurol. 2018;8:748. DOI: 10.3389/fneur.2017.00748.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Weigel K. PET Imaging and Glioblastoma. Neurosurgery. 2019. DOI: 10.1093/neuros/nyz001. NI3.</mixed-citation><mixed-citation xml:lang="en">Weigel K. PET Imaging and Glioblastoma. Neurosurgery. 2019. DOI: 10.1093/neuros/nyz001. NI3.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Brady LW, Heilmann H-P, Molls M, Nieder C. Radiation Oncology — An Evidence-Based Approach. Springer, 2008. Р. 483-96.</mixed-citation><mixed-citation xml:lang="en">Brady LW, Heilmann H-P, Molls M, Nieder C. Radiation Oncology — An Evidence-Based Approach. Springer, 2008. Р. 483-96.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Dissaux G, Dissaux B, Kabbaj OE, et al. Radiotherapy target volume definition in newly diagnosed high grade glioma using 18F-FET PET imaging and multiparametric perfusion MRI: a prospective study (IMAGG). Radiotherapy and Oncology. 2020. DOI: 10.1016/j.radonc.2020.06.025.</mixed-citation><mixed-citation xml:lang="en">Dissaux G, Dissaux B, Kabbaj OE, et al. Radiotherapy target volume definition in newly diagnosed high grade glioma using 18F-FET PET imaging and multiparametric perfusion MRI: a prospective study (IMAGG). Radiotherapy and Oncology. 2020. DOI: 10.1016/j.radonc.2020.06.025.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Ozyigit G, Selek U. Radiation Oncology. A Case-Based Review. Springer, 2019. P. 27-9.</mixed-citation><mixed-citation xml:lang="en">Ozyigit G, Selek U. Radiation Oncology. A Case-Based Review. Springer, 2019. P. 27-9.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Halperin EC, Perez CA, Brady LW. Perez and Brady’s Principles and Practice of Radiation Oncology. 6th ed. Lippincott Williams &amp; Wilkins, 2013. Р. 659-66.</mixed-citation><mixed-citation xml:lang="en">Halperin EC, Perez CA, Brady LW. Perez and Brady’s Principles and Practice of Radiation Oncology. 6th ed. Lippincott Williams &amp; Wilkins, 2013. Р. 659-66.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Hansen EK, Roach III M. Handbook of Evidence-Based Radiation Oncology. 3rd ed. Springer, 2018. Р. 58-66.</mixed-citation><mixed-citation xml:lang="en">Hansen EK, Roach III M. Handbook of Evidence-Based Radiation Oncology. 3rd ed. Springer, 2018. Р. 58-66.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Phillips TL, Hoppe RT, Roach III M. Leibel and Phillips Textbook of Radiation Oncology. 3rd ed. Philadelphia, USA: Saunders, 2010. Р. 421-522.</mixed-citation><mixed-citation xml:lang="en">Phillips TL, Hoppe RT, Roach III M. Leibel and Phillips Textbook of Radiation Oncology. 3rd ed. Philadelphia, USA: Saunders, 2010. Р. 421-522.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Brady LW, Heilmann H-P, Molls M, Nieder C. Decision Making in Radiation Oncology. Springer, 2011. Р. 917-20.</mixed-citation><mixed-citation xml:lang="en">Brady LW, Heilmann H-P, Molls M, Nieder C. Decision Making in Radiation Oncology. Springer, 2011. Р. 917-20.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Lee NY, Riaz N, Lu JJ. Target Volume Delineation for Conformal and Intensity-Modulated Radiation Therapy. Springer, 2015. Р. 424-38.</mixed-citation><mixed-citation xml:lang="en">Lee NY, Riaz N, Lu JJ. Target Volume Delineation for Conformal and Intensity-Modulated Radiation Therapy. Springer, 2015. Р. 424-38.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Yu J, Zhao F, Li M, et al. Delineation of radiation therapy target volumes for patients with postoperative glioblastoma: a review. OncoTargets and Therapy. 2016;9:3197-204. DOI: 10.2147/ott.s104241.</mixed-citation><mixed-citation xml:lang="en">Yu J, Zhao F, Li M, et al. Delineation of radiation therapy target volumes for patients with postoperative glioblastoma: a review. OncoTargets and Therapy. 2016;9:3197-204. DOI: 10.2147/ott.s104241.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Hau E, Shen H, Clark C, et al. The evolving roles and controversies of radiotherapy in the treatment of glioblastoma. J Med Rad Sci. 2016;63(2):114-23. DOI: 10.1002/jmrs.149.</mixed-citation><mixed-citation xml:lang="en">Hau E, Shen H, Clark C, et al. The evolving roles and controversies of radiotherapy in the treatment of glioblastoma. J Med Rad Sci. 2016;63(2):114-23. DOI: 10.1002/jmrs.149.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">DeVita Jr VT, Lawrence TS, Rosenberg SA, DeVita, Hellman, and Rosenberg’s Cancer: Principles and Practice of Oncology. 11th ed. Philadelphia: Wolters Kluwer, 2019. Р. 2791-97.</mixed-citation><mixed-citation xml:lang="en">DeVita Jr VT, Lawrence TS, Rosenberg SA, DeVita, Hellman, and Rosenberg’s Cancer: Principles and Practice of Oncology. 11th ed. Philadelphia: Wolters Kluwer, 2019. Р. 2791-97.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Jansen EP, et al. Target volumes in radiotherapy for high-grade malignant glioma of the brain. Radiotherapy and Oncology. 2000;56(2):151-6. DOI: 10.1016/s0167-8140(00)00216-4.</mixed-citation><mixed-citation xml:lang="en">Jansen EP, et al. Target volumes in radiotherapy for high-grade malignant glioma of the brain. Radiotherapy and Oncology. 2000;56(2):151-6. DOI: 10.1016/s0167-8140(00)00216-4.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Chang EL, et al. Evaluation of Peritumoral Edema in the Delineation of Radiotherapy Clinical Target Volumes for Glioblastoma. Int J Radiat Oncol Biol Phys. 2007;68(1):144-50. DOI: 10.1016/j.ijrobp.2006.12.009.</mixed-citation><mixed-citation xml:lang="en">Chang EL, et al. Evaluation of Peritumoral Edema in the Delineation of Radiotherapy Clinical Target Volumes for Glioblastoma. Int J Radiat Oncol Biol Phys. 2007;68(1):144-50. DOI: 10.1016/j.ijrobp.2006.12.009.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Minniti G, et al. Patterns of failure and comparison of different target volume delineations in patients with glioblastoma treated with conformal radiotherapy plus concomitant and adjuvant temozolomide. Radiother Oncol. 2010;97(3):377-81. DOI: 10.1016/j.radonc.2010.08.020.</mixed-citation><mixed-citation xml:lang="en">Minniti G, et al. Patterns of failure and comparison of different target volume delineations in patients with glioblastoma treated with conformal radiotherapy plus concomitant and adjuvant temozolomide. Radiother Oncol. 2010;97(3):377-81. DOI: 10.1016/j.radonc.2010.08.020.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Kumar N, et al. Impact of volume of irradiation on survival and quality of life in glioblastoma: a prospective, phase 2, randomized comparison of RTOG and MDACC protocols. Neuro-Oncology Practice. 2019;7(1):86-93. DOI: 10.1093/nop/npz024.</mixed-citation><mixed-citation xml:lang="en">Kumar N, et al. Impact of volume of irradiation on survival and quality of life in glioblastoma: a prospective, phase 2, randomized comparison of RTOG and MDACC protocols. Neuro-Oncology Practice. 2019;7(1):86-93. DOI: 10.1093/nop/npz024.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Niyazi M, et al. ESTRO-ACROP guideline ‘‘target delineation of glioblastomas”. Radiother Oncol. 2016. DOI: 10.1016/j.radonc.2015.12.003.</mixed-citation><mixed-citation xml:lang="en">Niyazi M, et al. ESTRO-ACROP guideline ‘‘target delineation of glioblastomas”. Radiother Oncol. 2016. DOI: 10.1016/j.radonc.2015.12.003.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Trifiletti DM, Zaorsky NG. Absolute Clinical Radiation Oncology Review. Springer, 2019. 98 p.</mixed-citation><mixed-citation xml:lang="en">Trifiletti DM, Zaorsky NG. Absolute Clinical Radiation Oncology Review. Springer, 2019. 98 p.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Ormond R, Bouras A, Moore M, et al. Central Nervous System and Peripheral Nerves. In: The American Cancer Society’s Oncology in Practice. Clinical Management. Wiley Blackwell, 2018. 582 p.</mixed-citation><mixed-citation xml:lang="en">Ormond R, Bouras A, Moore M, et al. Central Nervous System and Peripheral Nerves. In: The American Cancer Society’s Oncology in Practice. Clinical Management. Wiley Blackwell, 2018. 582 p.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Cabrera AR, Kirkpatrick JP, Fiveash JB, et al. Radiation therapy for glioblastoma: Executive summary of an American Society for Radiation Oncology Evidence-Based Clinical Practice Guideline. Pract Radiat Oncol. 2016;6(4):217-25. DOI: 10.1016/j.prro.2016.03.007.</mixed-citation><mixed-citation xml:lang="en">Cabrera AR, Kirkpatrick JP, Fiveash JB, et al. Radiation therapy for glioblastoma: Executive summary of an American Society for Radiation Oncology Evidence-Based Clinical Practice Guideline. Pract Radiat Oncol. 2016;6(4):217-25. DOI: 10.1016/j.prro.2016.03.007.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
